SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Medtech industry dominated by megamergers totaling $40 billion last year: report But companies are consolidating due to pressure to lower prices

Bringing the radiation risk discussion to the patient bedside Patients reluctantly in the dark when it comes to understanding imaging

Olympus unveils new FDA-endorsed reprocessing instructions for duodenoscopes New cleaning protocol achieves million-fold reduction in microbes

Senate adjourns with fate of SGR repeal uncertain, AMA voices displeasure AMA "extremely disappointed" with two week delay

Increase in minimally-invasive procedures could save U.S. hospitals $280 to $340 million annually: study Also has dramatic impact on complications, and length of hospital stay

C. difficile 30-day readmissions nearly double those from other causes: study Study offers profound insight for hospitals, which will be penalized under the Hospital-Acquired Condition Reduction Program that CMS is starting

FDA issues separate MRI recalls to GE and Siemens The unrelated recalls pertain to 132 Siemens MRI systems and 9,369 GE MRI systems

Studies have yet to demonstrate HIEs improve speed, quality, safety and cost: paper Too soon to say hospitals received money’s worth from HIEs, said researchers

Most ER physicians order unnecessary imaging tests: study But will malpractice reform have any effect on that?

House passes SGR repeal with overwhelming majority After a vote of 392 to 37, legislation will go to the Senate

Fred Upton (R-Mich.)

GOP seeks clarity on taxing smartphones, tablets, apps as medical devices

by Loren Bonner , DOTmed News Online Editor
Republicans on the House Energy and Commerce Committee, including chairman Fred Upton (R-Mich.), wrote to U.S. Food and Drug Commissioner Dr. Margaret Hamburg on March 1st asking her to clarify the uncertainly surrounding regulating mobile medical applications — a rapidly growing market. GOP lawmakers are concerned that smartphones, tablets and apps will be regulated as medical devices and therefore manufacturers will be subject to the excise tax under President Obama's health care law.

In July 2011, the FDA released draft guidance on how it intends to regulate those applications. The FDA has the authority under the Food Drug and Cosmetic Act to regulate certain products that meet the definition of a medical device, and applications more or less have the ability to turn mobile platforms into medical devices. In the draft, the FDA stated that they would likely regulate medical mobile apps that transform a device into a regulated medical device. However, they did explain that the manufacturer would not be considered a medical device maker unless they were marketing the product as being intended for medical users.

Story Continues Below Advertisement

Ventilators Plus-The Easy #1 Choice In Ventilator Sales, Rentals & Support.

Our name says it all ! Ventilators Plus is a full service depot repair facility offering on-site service as well. We BUY,SELL & RENT all models and also have a FULLY STOCKED parts warehouse available online 24/7. VISIT US !



Although the FDA is focused on 'intended use,' authors of the letter stated that they are "concerned about the potential of 'actual use' becoming a factor in the future."

They give the example of draft guidance issued by the FDA last year concerning commercially distributed in vitro diagnostic products. In this instance, the FDA indicated that 'actual use' would be a factor in their analysis of 'intended use.'

"If FDA determines that certain smartphone, tablet, or mobile medical apps are devices for the purposes of the FDCA [Food Drug and Cosmetic Act], it raises the possibility that they would also be subject to new taxes under the PPCA," stated the letter.

A 2.3 percent excise tax to medical device manufacturers was included in the Affordable Care Act to help raise roughly $30 billion over 10 years to offset the cost of the law.

In addition to clarification, the letter also asked the FDA to provide an update on when final guidance will be released. The FDA has been gathering public comments on the draft guidance since it was released in July 2011.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Center
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED